HOUSTON, November 18 /PRNewswire/ -- OrthoAccel Technologies, Inc., developers of the AcceleDent System (http://www.acceledent.com/), which is an acceleration device to enhance orthodontics, announced that Jeremy J. Mao, DDS, PhD (http://www.bme.columbia.edu/fac-bios/mao/faculty.html), Chairman of its Scientific Advisory Board, just completed a lecture tour in the United Kingdom, where he was invited to give three presentations over three days at three separate venues. AcceleDent is a simple, removable dental device that patients wear in the mouth for twenty minutes daily to accelerate orthodontic tooth movement. The first case in private practice (http://www.acceledent.com/2009/10/22/first-patient-in-united-kingdom-tre... with-acceledent/) was initiated last month in the United Kingdom.
The content of the UK lectures was focused on the biological basis for accelerating tooth movement that AcceleDent delivers as a benefit. Interestingly, these scientific principles have been used for decades in orthopaedic applications, with long bones, for example, explained Dr. Mao. Regulating the biology of bone tissue with vibrational force is actually nothing new, although OrthoAccel represents the first development toward an orthodontic benefit.
Dr. Mao's visits in the UK included two prestigious academic institutions and one annual conference. The lectures were given at the King's Dental Institute at King's College London (http://kcl.ac.uk/schools/dentistry/), the Eastman Dental Institute at the University College London (http://www.eastman.ucl.ac.uk/), and the British Orthodontic Society's (http://www.bos.org.uk/) 2009 Orthodontic Specialist Group annual meeting which was held at The Royal College of Physicians in London.
Mike Kaufman, VP Marketing for OrthoAccel commented, We are very excited about Dr. Mao's podium lectures to help us continue establishing credibility for this exciting new product in one of our most important markets.
Dr. Mao is the original inventor of the core OrthoAccel technology. When OrthoAccel was formed in 2007, he was recognized with the prestigious Iwao Yasuda Award for his discoveries in mechanical modulation of skeletal growth, among other areas. It represents the highest honor given by the Society for Physical Regulation in Biology and Medicine (http://www.sprbm.org/) to an individual who has made an outstanding contribution to the field of biomedical research.
In his lecture series, Dr. Mao challenged, Don't think like an orthodontist; think like an engineer for a moment. We move teeth with forces. A physical force has five fundamental properties: magnitude, direction, point of application, duration, and frequency. Regarding the introduction of AcceleDent which applies vibration at certain frequencies to the teeth to speed up movement, he added, As orthodontists, we have studied all of these characteristics extensively with the exception of frequency - until now. A device that delivers forces with rapidly oscillating frequencies leads us to a new area of clinical application. Dr. Mao currently serves as the Director of the Tissue Engineering Regenerative Medicine Laboratory (http://dental.columbia.edu/tel/) and Professor at the Columbia University College of Dental Medicine (http://dental.columbia.edu/) in New York.
OrthoAccel is presently controlling availability of AcceleDent in the United Kingdom to a select group of orthodontic specialists before a broader release in October 2010.
About OrthoAccel Technologies, Inc.
Based in Houston, Texas, OrthoAccel Technologies, Inc. is a privately owned medical device company currently engaged in the development, manufacturing, and marketing of products to enhance dental care and orthodontic treatment.
About the AcceleDent System
AcceleDent represents the first clinical approach to safely accelerate orthodontic tooth movement via modulating biology. The device has been studied clinically and applies gentle pulsing forces in combination with standard orthodontics to move teeth faster through accelerated bone remodeling. Importantly, the device works complementary with all existing orthodontic technologies. AcceleDent is neither FDA cleared nor FDA approved; it is currently investigational only in the United States. More information can be found at www.acceledent.com or requested via email@example.com
Media Contact Michael K. Lowe, CEO +1-832-631-1659
SOURCE: OrthoAccel Technologies, Inc.
CONTACT: Michael K. Lowe, CEO of OrthoAccel Technologies, Inc.,+1-832-631-1659